423 related articles for article (PubMed ID: 9533419)
1. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Hypertension; 1997 Aug; 30(2 Pt 1):278-87. PubMed ID: 9260993
[TBL] [Abstract][Full Text] [Related]
3. Losartan-induced attenuation of blood pressure in L-NAME hypertensive rats is associated with reversal of the enhanced expression of Gi alpha proteins.
Hashim S; Anand-Srivastava MB
J Hypertens; 2004 Jan; 22(1):181-90. PubMed ID: 15106810
[TBL] [Abstract][Full Text] [Related]
4. Role of the central nervous system in the development of hypertension produced by chronic nitric oxide blockade in rats.
Nakata T; Takeda K; Harada S; Oguni A; Hatta T; Kawa T; Itoh H; Sasaki S; Nakagawa M
Hypertens Res; 2001 Jan; 24(1):39-45. PubMed ID: 11213029
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibition by N(omega)-nitro-L-arginine methyl ester modulates G-protein expression and adenylyl cyclase activity in rat heart.
Di Fusco F; Anand-Srivastava MB
Am J Hypertens; 1997 Apr; 10(4 Pt 1):471-5. PubMed ID: 9128216
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of Gi proteins in non-hypertrophic hearts from rats with hypertension-induced by L-NAME treatment.
Di Fusco F; Anand-Srivastava MB
J Hypertens; 2000 Aug; 18(8):1081-90. PubMed ID: 10954000
[TBL] [Abstract][Full Text] [Related]
7. Selective peripheral regulation of noradrenaline and adrenaline release by nitric oxide.
Elayan HH; Kennedy BP; Ziegler MG
Clin Exp Pharmacol Physiol; 2002 Jul; 29(7):589-94. PubMed ID: 12060102
[TBL] [Abstract][Full Text] [Related]
8. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
[TBL] [Abstract][Full Text] [Related]
10. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
11. Redox modulation of Gi protein expression and adenylyl cyclase signaling: role of nitric oxide.
Anand-Srivastava MB; Di Fusco F
Antioxid Redox Signal; 2004 Apr; 6(2):385-92. PubMed ID: 15025940
[TBL] [Abstract][Full Text] [Related]
12. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
Lee BH; Shin HS
Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301
[TBL] [Abstract][Full Text] [Related]
13. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition.
Eshima K; Hirooka Y; Shigematsu H; Matsuo I; Koike G; Sakai K; Takeshita A
Hypertension; 2000 Aug; 36(2):259-63. PubMed ID: 10948087
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
16. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.
Jover B; Herizi A; Ventre F; Dupont M; Mimran A
Hypertension; 1993 Jun; 21(6 Pt 2):944-8. PubMed ID: 8505104
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat.
Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL
Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibition and renal alterations.
Jover B; Mimran A
J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S65-70. PubMed ID: 11811381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
